Theodore Iliopoulos
Direttore operativo presso Polpharma SA
Posizioni attive di Theodore Iliopoulos
Società | Posizione | Inizio | Fine |
---|---|---|---|
Polpharma SA
Polpharma SA Pharmaceuticals: MajorHealth Technology Polpharma SA develops and manufactures generic drugs. It offers food for special medical purposes, on prescription, no prescription, and medical products. The company was founded in 1935 and is headquartered in Starogard Gdanski, Poland. | Direttore operativo | 01/01/2002 | - |
Storia della carriera di Theodore Iliopoulos
Precedenti posizioni note di Theodore Iliopoulos
Società | Posizione | Inizio | Fine |
---|---|---|---|
PATHEON, INC. | Direttore operativo | - | - |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
Formazione di Theodore Iliopoulos
National & Kapodistrian University of Athens | Undergraduate Degree |
Statistiche
Distribuzione geografica
Polonia | 2 |
Grecia | 2 |
Stati Uniti | 2 |
Posizioni
Chief Operating Officer | 2 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Aziende private | 2 |
---|---|
Polpharma SA
Polpharma SA Pharmaceuticals: MajorHealth Technology Polpharma SA develops and manufactures generic drugs. It offers food for special medical purposes, on prescription, no prescription, and medical products. The company was founded in 1935 and is headquartered in Starogard Gdanski, Poland. | Health Technology |
Patheon, Inc.
Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |
- Borsa valori
- Insiders
- Theodore Iliopoulos
- Esperienza